SC 13G Filing

Company

Benitec Biopharma Inc.

Filed

February 9, 2022

Accession Number

0001816307-22-000006

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →